Pharmaceuticals and biologics manufacturer Catalent finished work on a $14 million project to add new biologics packaging assets to its Bloomington, IN biologics and sterile manufacturing facility, the company announced in a release Thursday. 

“The completion of this expansion marks a major milestone for our late-stage and commercial customers, allowing Catalent to focus on more complex device assembly and packaging needs for biologic products at higher volumes,” Mike Riley, region president, Biologics North America, said in a statement. “This state-of-the-art equipment adds to our growing network of global packaging capabilities alongside our Brussels, Belgium and Anagni, Italy drug product manufacturing sites.”

A new 15,000 sq ft addition at the Bloomington site contains five packaging suites and a quality control lab. The company installed three new packaging lines, including an Optima combination syringe assembly machine, an automated Mikron auto-injector assembly machine, and a Dividella NeoTOP top-load cartoner. 

“All three high-speed lines are fully qualified and ready to provide customers faster and more flexible packaging solutions for vials, syringes, and devices with no glass-to-glass contact,” the company said in the release. 

For more news headlines, articles, and equipment reviews, visit our Equipment Zones

More Powder & Bulk Solids articles:

84% of US Impacted by Shortages of High-Demand CPG

OSHA Issues Guidance to Counter N95 Respirator Shortages

15 Hospitalized After Ammonia Leak at Food Plant in RI